PERMA-FIX ENVIRONMENTAL SERVICES, INC. (NASDAQ:PESI) Files An 8-K Entry into a Material Definitive Agreement
Item 1.01 – Entry into a Material Definitive Agreement.
On June 20, 2019, Perma-Fix Environmental Services, Inc. and its subsidiaries (together, the “Company”) entered into another Amendment to its Amended and Restated Revolving Credit, Term Loan and Security Agreement dated October 31, 2011, as amended (“Loan Agreement”) with PNC Bank, National Association (“PNC”) as discussed under Item 2.03 below, which is incorporated herein by reference.
Section 2 – Financial Information
Item 2.03 – Creation of a Direct Financial Obligations or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant
On June 20, 2019, the Company and PNC entered into the twelfth amendment (“Amendment”) to its Loan Agreement. This Amended provided the following, among other things:
| 4.1 | Twelfth Amendment to Amended and Restated Revolving Credit, Term Loan and Security Agreement between PNC Bank, National Association and Perma-Fix Environmental Services, Inc., dated June 20, 2019. |
PERMA FIX ENVIRONMENTAL SERVICES INC Exhibit
EX-4.1 2 ex4-1.htm TWELFTH AMENDMENT TO AMENDED AND RESTATED REVOLVING CREDIT,…
To view the full exhibit click here
About PERMA-FIX ENVIRONMENTAL SERVICES, INC. (NASDAQ:PESI)
Perma-Fix Environmental Services, Inc. is an environmental and environmental technology know-how company. It operates in three segments: The Treatment Segment (Treatment), the Services Segment (Services) and the Medical Segment (Medical). Treatment includes nuclear, low-level radioactive, mixed (waste containing both hazardous and low-level radioactive waste), hazardous and non-hazardous waste treatment, processing and disposal services primarily through approximately four licensed and permitted treatment and storage facilities held by its subsidiaries. Services include on-site waste management services to commercial and government customers, technical services and nuclear services. The Medical segment includes research and development (R&D) of a new medical isotope production technology by its Polish subsidiary, Perma-Fix Medical S.A. (PF Medical). Its Treatment and Services provide services to research institutions, commercial companies, public utilities and governmental agencies.
